Insider Selling: CIGNA Co. (CI) EVP Sells 6,099 Shares of Stock

CIGNA Co. (NYSE:CI) EVP John M. Murabito sold 6,099 shares of the business’s stock in a transaction on Thursday, January 18th. The shares were sold at an average price of $220.10, for a total transaction of $1,342,389.90. Following the transaction, the executive vice president now directly owns 68,026 shares in the company, valued at $14,972,522.60. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.

Shares of CIGNA Co. (NYSE:CI) traded up $0.60 during trading on Monday, reaching $220.75. 880,890 shares of the company were exchanged, compared to its average volume of 1,176,685. The company has a market cap of $54,060.00, a PE ratio of 24.18, a price-to-earnings-growth ratio of 1.46 and a beta of 0.51. CIGNA Co. has a 52 week low of $141.93 and a 52 week high of $221.23. The company has a current ratio of 0.39, a quick ratio of 0.39 and a debt-to-equity ratio of 0.37.

CIGNA (NYSE:CI) last announced its quarterly earnings results on Thursday, November 2nd. The health services provider reported $2.83 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.36 by $0.47. The company had revenue of $10.38 billion for the quarter, compared to analysts’ expectations of $10.17 billion. CIGNA had a net margin of 5.74% and a return on equity of 18.85%. CIGNA’s revenue was up 5.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.94 EPS. research analysts anticipate that CIGNA Co. will post 10.34 earnings per share for the current fiscal year.

A number of analysts have recently commented on CI shares. Zacks Investment Research upgraded shares of CIGNA from a “hold” rating to a “buy” rating and set a $231.00 target price on the stock in a report on Friday, December 22nd. Royal Bank of Canada restated an “outperform” rating and set a $220.00 target price (up previously from $185.00) on shares of CIGNA in a report on Friday, November 3rd. Jefferies Group boosted their target price on shares of CIGNA from $221.00 to $231.00 and gave the company a “buy” rating in a report on Friday, November 3rd. Credit Suisse Group started coverage on shares of CIGNA in a report on Thursday, November 2nd. They set an “outperform” rating and a $219.00 target price on the stock. Finally, Goldman Sachs Group started coverage on shares of CIGNA in a report on Wednesday, January 3rd. They set a “neutral” rating and a $247.00 target price on the stock. Three investment analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $205.18.

A number of institutional investors have recently made changes to their positions in the stock. Investec Asset Management LTD lifted its stake in CIGNA by 35.4% during the 3rd quarter. Investec Asset Management LTD now owns 1,849,598 shares of the health services provider’s stock valued at $345,764,000 after acquiring an additional 483,904 shares during the period. Arrowstreet Capital Limited Partnership lifted its stake in CIGNA by 4,082.8% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 438,231 shares of the health services provider’s stock valued at $73,355,000 after acquiring an additional 427,754 shares during the period. Acadian Asset Management LLC lifted its stake in CIGNA by 80.8% during the 4th quarter. Acadian Asset Management LLC now owns 871,512 shares of the health services provider’s stock valued at $176,992,000 after acquiring an additional 389,590 shares during the period. Numeric Investors LLC lifted its stake in CIGNA by 76.0% during the 2nd quarter. Numeric Investors LLC now owns 714,702 shares of the health services provider’s stock valued at $119,634,000 after acquiring an additional 308,702 shares during the period. Finally, Bank of Montreal Can lifted its stake in CIGNA by 30.0% during the 4th quarter. Bank of Montreal Can now owns 1,232,172 shares of the health services provider’s stock valued at $250,243,000 after acquiring an additional 284,384 shares during the period. Institutional investors own 87.89% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Insider Selling: CIGNA Co. (CI) EVP Sells 6,099 Shares of Stock” was published by American Banking News and is owned by of American Banking News. If you are reading this report on another domain, it was copied illegally and republished in violation of U.S. and international copyright law. The correct version of this report can be accessed at https://www.americanbankingnews.com/2018/01/22/insider-selling-cigna-co-ci-evp-sells-6099-shares-of-stock.html.

CIGNA Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Insider Buying and Selling by Quarter for CIGNA (NYSE:CI)

Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply